David H. Crean, Ph.D is a Managing Partner at Cardiff Advisory. Previously, Dr. Crean served as Managing Director for Objective Capital Partners, a middle market investment banking firm located in southern California, where he led the firm’s Mergers and acquisitions (M&A), partnering, valuations and capital financing transactions with life science and healthcare companies. Dr. Crean has in excess of 25 years of transactional experience. Dr. Crean holds FINRA Series 79 and Series 63 licenses and is a FINRA Registered Investment Banking Representative through BA Securities, LLC.
E: firstname.lastname@example.org | P: 858-245-4905
In parallel to his investment banking and strategic advisory leadership for Cardiff Advisory, Dr. Crean currently serves as a Senior Advisor to Objective Capital's Investment Banking services, and is in leading roles on the Boards of Directors for Histogen, Inc. (Nasdaq: HSTO) as Board Chairman and Chair of Audit, and the California Life Sciences Association (CLSA) as Chairman of Development and a member of the Executive Committee. He is a limited partner with a leading life sciences venture fund, Mesa Verde Venture Partners, and a member of Corporate Directors Forum. Dr. Crean is also a contributing author for Forbes.com through his work with Forbes Los Angeles Business Council and a contributing author for PharmaBoardRoom.com. For his outstanding advisory work, Dr. Crean was recognized by San Diego Business Journal for SD500 Most Influential Business Leaders in 2019 and 2020, M&A Advisors for the 2019 Investment Banker of the Year, San Diego Business Journal’s 2018 Healthcare Hero, 2017 Thought Leader of the Year and 2017 Advisor of the Year Awards. Dr. Crean is also active in the non-profit sector where he serves in leading Board of Director roles for the Association for Corporate Growth (ACG) San Diego as President, and as Chairman of the Board for the Alzheimer’s Association of San Diego/ Imperial Counties and Student Success Programs of the Charter School of San Diego.
Dr. Crean holds a Masters of Business Administration (MBA) Degree with a finance concentration from Pepperdine University Graziadio School of Management. Additionally, he holds a Doctorate of Philosophy (Ph.D.) Degree in Biophysics and a Masters of Science (MS) Degree in Oncology from the State University of New York at Buffalo. Dr. Crean also earned a Bachelor of Science (BS) Degree in Biology/ Pre-Med from Canisius College.